JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Of all the Dragon Ball anime, GT has the tightest focus. It almost never removes Goku from the spotlight, and only a handful of characters are given the chance to ever truly share it with him. What's ...

The makers had already announced that the teaser of this upcoming film would be released on Salman Khan's 2024 birthday but even before that, the actor has shared a new poster with his fans.

On Thursday, Salman took to social media: Instagram and Twitter to share the first poster which gives a glimpse of his look in the film. He shared that the teaser will drop tomorrow. The newly ...

A new poster of Salman Khan-starrer Sikandar has been unveiled ahead of his birthday. It features the actor's first look from the AR Murugadoss film, where he can be seen carrying a spear. Listen to ...

Sajid Nadiadwala’s upcoming magnum opus, Sikandar, has unveiled its first look poster, and it’s nothing short of iconic. A.R. Murugadoss known for his cinematic experience is all set to ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...

The foot is a complex structure made up of 28 bones, 33 joints, 19 muscles, over 100 tendons and ligaments, and more than 200,000 different nerve endings. These work together to allow you to walk, run ...

For years, that aimless scrolling was handled by the film posters which festooned cinemas, bus shelters and other public areas through the land. The right poster can evoke a film without words, stir ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.